Approximately 30% of epilepsy patients develop a drug‐refractory epilepsy, that is, seizures cannot be controlled with antiepileptic drugs. Surgery has been evaluated as an effective but costly form of treatment.… Click to show full abstract
Approximately 30% of epilepsy patients develop a drug‐refractory epilepsy, that is, seizures cannot be controlled with antiepileptic drugs. Surgery has been evaluated as an effective but costly form of treatment. The aim of this systematic review is to synthesize the available evidence on the cost‐effectiveness of surgical treatment compared to medical treatment for these patients.
               
Click one of the above tabs to view related content.